Delivery Order SPE2DB25D3012-SPE2DB25FXAKT
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,315.50 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials, with an ultimate completion date of June 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and designates Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,925.36 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This contract type represents a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,426.20 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of September 4, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,193.89 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Remifentanil is a potent synthetic opioid analgesic commonly used in medical and surgical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.00 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This firm fixed-price contract, issued on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a competitive award with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Remifentanil is a potent synthetic...
- The Defense Logistics Agency awarded a delivery order valued at $3,635.77 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials. This contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Remifentanil 2 mg vials with a ceiling value of $1,675.46. The contract utilizes a firm fixed price structure and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded with no...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 1 mg vials of the pharmaceutical drug Remifentanil. The $1,063.41 firm fixed price delivery order contract has an ultimate completion date of September 10, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply this critical care medication to support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit organization and subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,906.35, is for the supply of 1 mg vials of the pharmaceutical drug remifentanil. The delivery order has an ultimate completion date of March 11, 2024. Additionally, AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Remifentanil 1 mg vials with a contract value of $3,667.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a small-value transaction within AmerisourceBergen...